Multicenter, retrospective study to assess the safety and efficacy of combination therapy with combination ophthalmic solutions for glaucoma in patients with primary open-angle glaucoma or ocular hypertension
Latest Information Update: 26 Oct 2022
At a glance
- Drugs Brimonidine/brinzolamide (Primary) ; Carteolol/latanoprost (Primary)
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Therapeutic Use
Most Recent Events
- 21 Oct 2022 Status changed from active, no longer recruiting to completed.
- 31 Jan 2022 New trial record